NOT KNOWN DETAILS ABOUT MOLNUPIRAVIR

Pharmacological inhibition on the ataxia telangiectasia and Rad3-connected protein serine/threonine kinase (ATR; often called FRAP-connected protein (FRP1)) has emerged as a promising tactic for cancer treatment method that exploits synthetic lethal interactions with proteins involved in DNA destruction fix, overcomes resistance to other therapies